GLOBAL HORMONE REPLACEMENT THERAPY MARKET 2021-2028
TABLE OF CONTENTS
1. GLOBAL HORMONE REPLACEMENT THERAPY
MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON HORMONE
REPLACEMENT THERAPY MARKET
2.2. KEY INSIGHTS
1.1.1. INTRODUCTION OF NEW DRUG DELIVERY
SYSTEMS FOR HORMONE REPLACEMENT
1.1.2. MODERN SEDENTARY LIFESTYLES
1.2. PORTER’S FIVE FORCES MODEL
1.2.1. THREAT OF NEW ENTRANTS
1.2.2. THREAT OF SUBSTITUTE PRODUCTS
1.2.3. BARGAINING POWER OF BUYERS
1.2.4. BARGAINING POWER OF SUPPLIERS
1.2.5. COMPETITIVE RIVALRY
1.3. MARKET ATTRACTIVENESS INDEX
1.4. VENDOR SCORECARD
1.5. KEY STRATEGIC DEVELOPMENTS
1.5.1. ACQUISITIONS & MERGERS
1.5.2. PRODUCT LAUNCH & DEVELOPMENTS
1.5.3. CONTRACTS AND PARTNERSHIPS
1.5.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS,
& DIVESTITURES
1.6. MARKET DRIVERS
1.6.1. RISE IN AWARENESS PERTAINING TO
HEALTH PROBLEMS DURING MENOPAUSE
1.6.2. INCREASE IN PREVALENCE OF HORMONAL
DISORDERS
1.6.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS
1.7. MARKET RESTRAINTS
1.7.1. HIGH COST OF TREATMENT
1.7.2. ADVERSE REACTIONS ASSOCIATED WITH
HORMONE REPLACEMENT THERAPY
1.8. MARKET OPPORTUNITIES
1.8.1. AVAILABILITY OF ALTERNATIVE THERAPY
OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
1.8.2. LAUNCH OF TELEMEDICINE CLINICAL
PRACTICE SERVICES
2. GLOBAL HORMONE REPLACEMENT THERAPY
MARKET - BY THERAPY TYPE
2.1. ESTROGEN HORMONE REPLACEMENT THERAPY
2.2. THYROID HORMONE REPLACEMENT THERAPY
2.3. TESTOSTERONE HORMONE REPLACEMENT
THERAPY
2.4. HUMAN GROWTH HORMONE REPLACEMENT
THERAPY
2.5. PROGESTOGEN HORMONE REPLACEMENT
THERAPY
3. GLOBAL HORMONE REPLACEMENT THERAPY
MARKET - BY TYPE OF DISEASE
3.1. MENOPAUSE
3.2. MALE HYPOGONADISM
3.3. GROWTH HORMONE DEFICIENCY
3.4. HYPOTHYROIDISM
3.5. OTHER TYPE OF DISEASES
4. GLOBAL HORMONE REPLACEMENT THERAPY
MARKET - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. PARENTERAL
4.3. TRANSDERMAL
4.4. OTHER ROUTES OF ADMINISTRATION
5. GLOBAL HORMONE REPLACEMENT THERAPY
MARKET – REGIONAL OUTLOOK
5.1. NORTH AMERICA
5.1.1. MARKET BY THERAPY TYPE
5.1.2. MARKET BY TYPE OF DISEASE
5.1.3. MARKET BY ROUTE OF ADMINISTRATION
5.1.4. COUNTRY ANALYSIS
1.1.1.1.
UNITED
STATES
1.1.1.2.
CANADA
1.2. EUROPE
5.1.5. MARKET BY THERAPY TYPE
5.1.6. MARKET BY TYPE OF DISEASE
5.1.7. MARKET BY ROUTE OF ADMINISTRATION
5.1.8. COUNTRY ANALYSIS
1.1.1.1.
GERMANY
1.1.1.2.
FRANCE
1.1.1.3.
UNITED
KINGDOM
1.1.1.4.
ITALY
1.1.1.5.
RUSSIA
1.1.1.6.
SPAIN
1.1.1.7.
REST
OF EUROPE
1.2. ASIA-PACIFIC
5.1.9. MARKET BY THERAPY TYPE
5.1.10.
MARKET
BY TYPE OF DISEASE
5.1.11.
MARKET
BY ROUTE OF ADMINISTRATION
5.1.12.
COUNTRY
ANALYSIS
1.1.1.1.
CHINA
1.1.1.2.
JAPAN
1.1.1.3.
INDIA
1.1.1.4.
AUSTRALIA
& NEW ZEALAND
1.1.1.5.
SOUTH
KOREA
1.1.1.6.
ASEAN
COUNTRIES
1.1.1.7.
REST
OF ASIA-PACIFIC
1.2. LATIN AMERICA
5.1.13.
MARKET
BY THERAPY TYPE
5.1.14.
MARKET
BY TYPE OF DISEASE
5.1.15.
MARKET
BY ROUTE OF ADMINISTRATION
5.1.16.
COUNTRY
ANALYSIS
1.1.1.1.
MEXICO
1.1.1.2.
BRAZIL
1.1.1.3.
REST
OF LATIN AMERICA
1.2. MIDDLE EAST AND AFRICA
5.1.17.
MARKET
BY THERAPY TYPE
5.1.18.
MARKET
BY TYPE OF DISEASE
5.1.19.
MARKET
BY ROUTE OF ADMINISTRATION
5.1.20.
COUNTRY
ANALYSIS
1.1.1.1.
SAUDI
ARABIA
1.1.1.2.
UNITED
ARAB EMIRATES
1.1.1.3.
TURKEY
1.1.1.4.
SOUTH
AFRICA
1.1.1.5.
REST
OF MIDDLE EAST & AFRICA
2. COMPETITIVE LANDSCAPE
1.1. ABBOTT LABORATORIES
1.2. AMGEN
1.3. ANI PHARMACEUTICALS
1.4. BAYER AG
1.5. DR REDDY’S LABORATORIES LTD
1.6. ELI LILLY & COMPANY
1.7. GENENTECH INC
1.8. IPSEN
1.9. MERCK KGAA
1.10.
NOVARTIS
AG
1.11.
NOVEN
PHARMACEUTICALS INC
1.12.
NOVO
NORDISK A/S
1.13.
PFIZER
INC
1.14.
TEVA
PHARMACEUTICAL INDUSTRIES LTD
1.15.
VIATRIS
INC (MYLAN NV)
2. RESEARCH METHODOLOGY & SCOPE
2.1. RESEARCH SCOPE & DELIVERABLES
5.1.21.
OBJECTIVES
OF STUDY
5.1.22.
SCOPE
OF STUDY
5.2. SOURCES OF DATA
5.2.1. PRIMARY DATA SOURCES
5.2.2. SECONDARY DATA SOURCES
5.3. RESEARCH METHODOLOGY
5.3.1. EVALUATION OF PROPOSED MARKET
5.3.2. IDENTIFICATION OF DATA SOURCES
5.3.3. ASSESSMENT OF MARKET DETERMINANTS
5.3.4. DATA COLLECTION
5.3.5.
DATA
VALIDATION & ANALYSIS
LIST OF TABLES
TABLE
1: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE
2: VENDOR SCORECARD
TABLE
3: LIST OF ACQUISITIONS & MERGERS
TABLE
4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE
5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE
6: LIST OF BUSINESS EXPANSIONS,
ANNOUNCEMENTS, AND DIVESTITURES
TABLE
7: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE
8: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE
9: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE
10: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE
11: NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
12: NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE
13: NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE
14: NORTH AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE
15: EUROPE HORMONE REPLACEMENT THERAPY,
BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
16: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE
17: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE
18: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE
19: ASIA-PACIFIC HORMONE REPLACEMENT
THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
20: ASIA-PACIFIC HORMONE REPLACEMENT
THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE
21: ASIA-PACIFIC HORMONE REPLACEMENT
THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE
22: ASIA-PACIFIC HORMONE REPLACEMENT
THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE
23: LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
24: LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE
25: LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE
26: LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE
27: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
28: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE
29: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE
30: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
LIST OF FIGURES
FIGURE
1: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
2: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE
3: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
FIGURE
4: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
FIGURE
5: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
FIGURE
6: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
FIGURE
7: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)
FIGURE
8: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE
9: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE
10: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE
11: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)
FIGURE
12: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE
13: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE
14: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE
15: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE
16: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE
17: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE
18: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE
19: UNITED STATES HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
20: CANADA HORMONE REPLACEMENT THERAPY MARKET
2021-2028 (IN $ MILLION)
FIGURE
21: GERMANY HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
22: FRANCE HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
23: UNITED KINGDOM HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
24: ITALY HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
25: RUSSIA HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
26: SPAIN HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
27: REST OF EUROPE HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: CHINA HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
29: JAPAN HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
30: INDIA HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
31: AUSTRALIA & NEW ZEALAND HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
32: SOUTH KOREA HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
33: ASEAN COUNTRIES HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
34: REST OF ASIA-PACIFIC HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
35: MEXICO HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
36: BRAZIL HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
37: REST OF LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
38: SAUDI ARABIA HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
39: UNITED ARAB EMIRATES HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
40: TURKEY HORMONE REPLACEMENT THERAPY
MARKET 2021-2028 (IN $ MILLION)
FIGURE
41: SOUTH AFRICA HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE
42: REST OF MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
MARKET OUTLOOK
Triton
Market Research estimates the global hormone replacement therapy market to
witness growth at a CAGR of 7.75% over the predicted period of 2021-2028.
Factors
like an increase in awareness about health problems arising during menopause,
the surge in occurrence of hormonal disorders, and new product launches by
prominent players are supporting the growth of the market globally. In
addition, the availability of alternative therapy offers unique opportunities
for the studied market over the estimated period.
However,
hormone treatments include high-quality medications, customized treatment plans,
and follow-up appointments. This indicates the cost of such treatments to be
relatively on a higher side, restricting the development of the hormone
replacement therapy market.
REGIONAL OUTLOOK
The
global hormone replacement therapy market encompasses the regions of North
America, the Asia-Pacific, Latin America, Europe, and the Middle East and
Africa.
Globally,
the Asia-Pacific is anticipated to observe the fastest growth rate in the
hormone replacement therapy market over the forecast period. The region’s
robust growth can be attributed to several factors, including advancement in
the healthcare services pertaining to menopausal and hormonal imbalance
disorders. Furthermore, the increase in awareness among the population base in
the region’s nations adds to the market’s growth. Along with this, the high
growth in the number of geriatric populations is another crucial factor
responsible for the progress of the hormonal replacement therapy market within
the Asia-Pacific region.
COMPETITIVE OUTLOOK
The
major players in the hormone replacement therapy market include Abbott
Laboratories, Amgen, Genentech Inc, Pfizer Inc, ANI Pharmaceuticals, Eli Lilly
& Company, Teva Pharmaceutical Industries Ltd, Ipsen, Bayer AG, Noven
Pharmaceuticals Inc, Novo Nordisk A/S, Merck KGAA, Viatris Inc (Mylan NV), Dr
Reddy’s Laboratories Ltd, and Novartis AG.
Abbott
Laboratories is among the leading pharmaceutical companies involved in
developing, manufacturing, and marketing a wide range of healthcare products.
It provides its clientele with diagnostic systems, neuromodulation devices,
medical devices, and generic pharmaceuticals, among others. Its product line
includes Duphaston tablets used to treat menstrual disorders triggered by a
lack of hormones. Abbott has operations across multiple regions, with
headquarters in the United States.
Get
more insights into the Global Hormone Replacement Therapy Market:
https://www.tritonmarketresearch.com/reports/hormone-replacement-therapy-market
SEGMENTATION
1. ABBOTT LABORATORIES
2. AMGEN
3. ANI PHARMACEUTICALS
4. BAYER AG
5. DR REDDY’S LABORATORIES LTD
6. ELI LILLY & COMPANY
7. GENENTECH INC
8. IPSEN
9. MERCK KGAA
10. NOVARTIS AG
11. NOVEN PHARMACEUTICALS INC
12. NOVO NORDISK A/S
13. PFIZER INC
14. TEVA PHARMACEUTICAL INDUSTRIES LTD
Comments
Post a Comment